Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Releases Earnings Results, Misses Estimates By $0.10 EPS

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) issued its earnings results on Tuesday. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.10), Zacks reports. Bayer Aktiengesellschaft had a positive return on equity of 16.96% and a negative net margin of 2.74%. The firm had revenue of $10.96 billion during the quarter. Bayer Aktiengesellschaft updated its FY 2024 guidance to 5.610-6.045 EPS.

Bayer Aktiengesellschaft Stock Performance

Shares of Bayer Aktiengesellschaft stock traded down $0.87 during trading hours on Wednesday, hitting $5.58. 4,104,154 shares of the company’s stock traded hands, compared to its average volume of 1,120,233. Bayer Aktiengesellschaft has a 12-month low of $5.49 and a 12-month high of $11.33. The company has a fifty day simple moving average of $7.44 and a 200-day simple moving average of $7.43. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 1.04.

Analyst Ratings Changes

Separately, Bank of America upgraded Bayer Aktiengesellschaft from an “underperform” rating to a “neutral” rating in a report on Friday, September 6th. One equities research analyst has rated the stock with a sell rating and eight have issued a hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold”.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.